| Disease | hepatocellular carcinoma |
| Phenotype | C0345905|intrahepatic cholangiocarcinoma |
| Sentences | 1 |
| PubMedID- 22723030 | Recently, the aasld removed ceus from their guidelines in part because of the perceived possibility of false-positive hepatocellular carcinoma (hcc) diagnosis in patients with intrahepatic cholangiocarcinoma (icc), and in part because ceus is not available in the usa. |
Page: 1